Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine oral solution for asthma and viral wheezing in young allergic children
ChiCTR2400092021Phase 4Not yet recruiting
- Sponsor
- West China Second University Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levocetirizine in asthma (2 arms), sponsored by West China Second University Hospital. Primary endpoint: Therapeutic effectiveness. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
levocetirizine
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR2400092021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092021.